about
Selective pre-priming of HA-specific CD4 T cells restores immunological reactivity to HA on heterosubtypic influenza infection.Is seasonal vaccination a contributing factor to the selection of influenza epidemic variants?Adaptive mutations of neuraminidase stalk truncation and deglycosylation confer enhanced pathogenicity of influenza A viruses.From Original Antigenic Sin to the Universal Influenza Virus Vaccine.Heterosubtypic cross-reactivity of HA1 antibodies to influenza A, with emphasis on nonhuman subtypes (H5N1, H7N7, H9N2).Immune responses in influenza A virus and human coronavirus infections: an ongoing battle between the virus and host.Predictive Modeling of Influenza Shows the Promise of Applied Evolutionary Biology.Maternal antibodies' role in immunity-Response.Impact of age and pre-existing influenza immune responses in humans receiving split inactivated influenza vaccine on the induction of the breadth of antibodies to influenza A strains.Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.Pandemic Paradox: Early Life H2N2 Pandemic Influenza Infection Enhanced Susceptibility to Death during the 2009 H1N1 Pandemic.Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.Poor immunogenicity, not vaccine strain egg adaptation, may explain the low H3N2 influenza vaccine effectiveness in 2012-13.Broad cross-reactive IgG responses elicited by adjuvanted vaccination with recombinant influenza hemagglutinin (rHA) in ferrets and mice.Epidemiological Studies to Support the Development of Next Generation Influenza Vaccines.Mini-hemagglutinin vaccination induces cross-reactive antibodies in pre-exposed NHP that protect mice against lethal influenza challenge.Characterization of Hemagglutinin Antigens on Influenza Virus and within Vaccines Using Electron Microscopy.Sera from Individuals with Narrowly Focused Influenza Virus Antibodies Rapidly Select Viral Escape MutationsThe Hurdles From Bench to Bedside in the Realization and Implementation of a Universal Influenza VaccineImmunodominance of Antigenic Site B in the Hemagglutinin of the Current H3N2 Influenza Virus in Humans and MiceTimescales of influenza A/H3N2 antibody dynamics
P2860
Q30401866-C7788DF6-9213-4097-A09A-64B99F541CE5Q38635123-6CB2172B-CAD5-4310-8832-B2A4E63E2546Q40052151-D4F0D6EE-7968-46F6-BA43-17013D2AB729Q40059787-DA62415D-E3B2-4B64-9630-483B10AAB7CCQ40120056-8E897F0B-078F-4B85-890C-94E63DDA1CC2Q45324307-DF109BA5-BCF8-4824-BAE8-1562A2F0AEDCQ45951581-562B9761-88FB-48C0-BECD-9F461C1E3047Q45991137-EDD23396-5B5E-4DBF-819A-7ECA9ADA3C6EQ47128858-3FB700E3-3618-4348-893F-30FD48296281Q47150783-FA2204D5-21A6-4940-94EA-70C37B772E30Q47552843-B61B0BE2-1CC2-409C-89EE-D1E70EA1E2DAQ47613621-427AB779-0CF5-4CDD-AEF1-F84098DA3C0BQ51151777-55E6407C-E86B-47B7-8588-1DCA22A2F64BQ52594170-46C40134-7C05-4D83-B7ED-142F0B9D12A6Q52627557-704625E6-CCFD-4D6F-980F-179F8B063463Q55518397-A8A44678-0730-4C7E-A5DE-A4F0D74B4247Q55689231-D11BA952-6A7A-4B8D-8FEB-97BDBC8E7567Q56888365-8DFF78E6-6A2B-4E00-A866-F3E660058D29Q57094348-C92B3FC6-41A4-4D75-9CE2-3A22BC36453BQ57469949-AB656888-206B-4F9C-951C-9274757FFBDEQ58734451-82038AF8-1DD9-4710-B7D4-12EDE9F2D661
P2860
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Immune history and influenza virus susceptibility.
@en
Immune history and influenza virus susceptibility.
@nl
type
label
Immune history and influenza virus susceptibility.
@en
Immune history and influenza virus susceptibility.
@nl
prefLabel
Immune history and influenza virus susceptibility.
@en
Immune history and influenza virus susceptibility.
@nl
P2860
P1476
Immune history and influenza virus susceptibility.
@en
P2093
Sarah Cobey
Scott E Hensley
P2860
P304
P356
10.1016/J.COVIRO.2016.12.004
P50
P577
2017-01-12T00:00:00Z